Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay H Traverse

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Open Heart|July 8, 2021
Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trialMohammad R Ostovaneh, Raj R Makkar, Bharath Ambale-Venkatesh, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac ArrestMohamed A Omer, Jeffrey M Tyler, Timothy D Henry, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
Cardiovascular Research|August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular useDoris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|August 4, 2007
A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarctionTimothy D Henry, Scott W Sharkey, M Nicholas Burke, et al.
European Heart Journal|August 5, 2020
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trialRaj R Makkar, Dean J Kereiakes, Frank Aguirre, et al.
The Journal of Invasive Cardiology|September 28, 2023
Incidence, treatment and outcomes of coronary artery dissection during percutaneous coronary interventionElizabeth Page, Spyridon Kostantinis, Judit Karacsonyi, et al.
Nature Medicine|October 21, 2025
Cardiotropic AAV gene therapy for heart failure: a phase 1 trialTimothy D Henry, Eugene S Chung, Monica Alvisi, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Open Heart|July 8, 2021
Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trialMohammad R Ostovaneh, Raj R Makkar, Bharath Ambale-Venkatesh, et al.
Circulation Research|July 9, 2011
Intramyocardial, autologous CD34+ cell therapy for refractory anginaDouglas W Losordo, Timothy D Henry, Charles Davidson, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac ArrestMohamed A Omer, Jeffrey M Tyler, Timothy D Henry, et al.
American Heart Journal|January 18, 2025
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemiaGerard T Portela, Gregory Ducrocq, Marnie Bertolet, et al.
Cardiovascular Research|August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular useDoris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|August 4, 2007
A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarctionTimothy D Henry, Scott W Sharkey, M Nicholas Burke, et al.
European Heart Journal|August 5, 2020
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trialRaj R Makkar, Dean J Kereiakes, Frank Aguirre, et al.
The Journal of Invasive Cardiology|September 28, 2023
Incidence, treatment and outcomes of coronary artery dissection during percutaneous coronary interventionElizabeth Page, Spyridon Kostantinis, Judit Karacsonyi, et al.
Nature Medicine|October 21, 2025
Cardiotropic AAV gene therapy for heart failure: a phase 1 trialTimothy D Henry, Eugene S Chung, Monica Alvisi, et al.
Pageof 10